Exploring how gut health affects brain damage from cadmium exposure
Understanding the role of the gut-brain axis in modulating Cadmium neurotoxicity
This study is looking at how a harmful metal called cadmium affects both gut health and memory, and it aims to find out if changing gut bacteria can help protect the brain from these negative effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11106022 on NIH RePORTER |
What this research studies
This research investigates the connection between gut health and brain function, specifically how exposure to cadmium, a harmful heavy metal, can lead to learning and memory problems. The study will analyze changes in gut bacteria and their metabolites when cadmium exposure occurs, aiming to understand if these gut changes contribute to brain toxicity. By using animal models, researchers will explore whether altering gut bacteria can influence the effects of cadmium on cognitive abilities. This approach could reveal new insights into preventing or mitigating neurotoxicity linked to environmental toxins.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals exposed to cadmium or those with cognitive impairments related to neurotoxic exposure.
Not a fit: Patients who are not exposed to cadmium or do not have cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for protecting brain health from environmental toxins like cadmium.
How similar studies have performed: Other studies have shown promising results in understanding the gut-brain axis, but this specific investigation into cadmium neurotoxicity is relatively novel.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Wang, Hao — University of Michigan at Ann Arbor
- Study coordinator: Wang, Hao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.